|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 82.60 EUR | -0.30% |
|
-0.18% | +5.90% |
| 06-15 | Kerry Group Director Fiona Dawson buys GBP148,519 shares | AN |
| 05-11 | Bio-K+ Advances Research on Gut Health and Autism Spectrum Disorder with Clinical Study Findings | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 84.75 | 84.75 | 83.9 |
| Spread/Res. | -2.54% | -2.54% | -1.55% |
| Spread/Supp. | +4.29% | +14.80% | +10.28% |
| Support | 79.2 | 71.95 | 74.9 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- KRZ Stock
- Charts Kerry Group plc
Select your edition
All financial news and data tailored to specific country editions
